Couverture de News&ViewsPodcast | Tobacco Asia - InterTabac

News&ViewsPodcast | Tobacco Asia - InterTabac

News&ViewsPodcast | Tobacco Asia - InterTabac

De : Glenn Anthony John | InterTabac - Messe Dortmund
Écouter gratuitement

À propos de ce contenu audio

 The series "Tobacco & Vape, News & Views, presented by Business Insights of InterTabac/ InterSupply and Tobacco Asia magazine" is a podcast series with host Thomas Schmid, contributing editor of Tobacco Asia magazine.Tobacco Asia - InterTabac Economie
Épisodes
  • TobaccoAsia/ InterTabac Podcast #54

    TobaccoAsia/ InterTabac Podcast #54
    May 11 2026
    Thomas Schmid interviews Mark McQuillan, the managing director of Nicobrand, one of the world's largest pharmaceutical-grade nicotine suppliers. McQuillan explains what truly qualifies nicotine as "pharmaceutical grade." For instance, beyond basic monographs, it requires regulatory audits, drug master files, and strict impurity controls. McQuillan argues that all next-generation products like pouches and e-liquids should use pharma-grade nicotine to ensure consumer safety. The global nicotine market is roughly 1,000–1,500 metric tons annually, with nicotine pouches growing fastest. McQuillan also stresses the importance of supply chain transparency and correcting the widespread misconception that nicotine itself causes cancer.
    Afficher plus Afficher moins
    24 min
  • TobaccoAsia/ InterTabac Podcast #53

    TobaccoAsia/ InterTabac Podcast #53
    Apr 2 2026
    In this episode, Thomas Schmid speaks with developmental neurobiologist Dr. Charles A. Gardner about the demonization of nicotine. Gardner explains that nicotine has been wrongly conflated with tobacco and smoking, leading to widespread misinformation — including 80% of US physicians falsely believing nicotine causes cancer. Gardner argues that safer alternatives like vapes, pouches, and snus are vital harm reduction tools, yet prohibitionist policies often ban them while leaving deadly cigarettes legal. Prohibition, he notes, drives products underground and worsens outcomes. Gardner also highlights nicotine's potential health benefits: helping prevent Parkinson's and Alzheimer's, reducing symptoms of ADHD, Tourette’s syndrome, BPD, and schizophrenia, improving focus, and decreasing anxiety. To shift public perception, he advocates amplifying voices of older ex-smokers who quit cigarettes by using reduced risk products, echoing strategies from cannabis activism. His core message: nicotine is not the enemy — preventable deaths from combustible cigarettes are. Policy should prioritize harm reduction over demonizing a molecule.
    Afficher plus Afficher moins
    26 min
  • TobaccoAsia/ InterTabac Podcast #52

    TobaccoAsia/ InterTabac Podcast #52
    Mar 2 2026
    Thomas Schmid interviews Waqas Khan, global CEO of Clew, discussing how the nicotine pouch brand became the world's third-largest by distribution in just two and a half years. Khan attributes this rapid success to building a complete manufacturing ecosystem with pharma-grade facilities and prioritizing quality over cost. The brand has launched in 50 countries across five regional hubs, customizing products for local taste preferences. A major achievement has been penetrating the travel retail sector, with Clew now present in over 15 duty-free locations worldwide. Khan explains how the brand pioneered nicotine pouch listings in challenging markets like Thailand by working directly with regulators and demonstrating FDA authorization. The conversation also covers recent expansions into Colombia, Sweden, Morocco, and the Philippines, plus insights on navigating complex regulatory environments in markets like Japan and China's evolving nicotine regulations.
    Afficher plus Afficher moins
    22 min
adbl_web_anon_alc_button_suppression_c
Aucun commentaire pour le moment